Lynn Macdonald

Senior Vice President, Research · Regeneron Pharmaceuticals

Biopharmaceuticals

Lynn Macdonald is senior vice president of research at Regeneron Pharmaceuticals. She joined in 1999 and leads antibody technology centers and research operations, with contributions to the company’s VelociGene and VelocImmune technologies.

Last reviewed: Oct 21, 2026

Lynn Macdonald

Senior Vice President, Research Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Lynn Macdonald is senior vice president of research at Regeneron Pharmaceuticals. She joined in 1999 and leads antibody technology centers and research operations, with contributions to the company’s VelociGene and VelocImmune technologies.

Career Highlights

  • Joined Regeneron in 1999.
  • Contributed to development of VelociGene and the VelocImmune mouse.
  • Leads technology centers, core research groups and research and preclinical operations.

Professional Journey

Macdonald completed a postdoctoral fellowship at Columbia University before working at Cadus Pharmaceuticals. She joined Regeneron in 1999.

Her work contributed to Regeneron’s VelociSuite genomics technologies, including development of VelociGene and the VelocImmune mouse. These are technology contributions documented by the company rather than a claim that she alone created the platforms.

As senior vice president of Research, she heads several technology centers generating antibody therapeutics. Her responsibilities also include DNA, biobanking and automation core groups, together with research and preclinical development operations. The role brings research infrastructure and technology development within a common leadership portfolio.

Education

Macdonald earned a BS from the University of Rochester and a PhD from the State University of New York.